Woman Sent Plea to Doctors, Saying ‘Please Help Me, Something’s Wrong.’ She Then Was Diagnosed with an Extremly Rare Condition

**Woman’s Health Struggles Highlight Importance of Self-Advocacy in Medical Care**

Michelle Williams’ journey through health challenges has shed light on the urgent need for patients to advocate for themselves within the healthcare system. Initially dismissed by a medical professional, Williams faced significant hurdles before receiving a diagnosis of a rare kidney condition, underscoring the vital role that self-advocacy can play in securing appropriate medical care.

Her health difficulties began during the COVID-19 pandemic, where she was balancing the demands of parenting young children and renovating a farmhouse with her husband. Williams developed high blood pressure, which, at first, she attributed to the stress of her busy life. As time progressed, however, more alarming symptoms emerged, including swelling in her legs, persistent fatigue, and frequent nighttime trips to the bathroom.

After being referred to a kidney specialist, Williams’ hopes for answers were dashed when a physician’s assistant dismissed her concerns. According to CBS News, the assistant ignored Williams’ detailed medical records and suggested only basic lifestyle modifications to lower her blood pressure, recommending that she return in six months for a follow-up. Williams recounted the experience vividly, describing a sense of depression and frustration as she felt her symptoms were not taken seriously. “I didn’t really feel like I had six months to wait,” she recalled.

Determined to seek a comprehensive evaluation, Williams opted to refer herself to the Cleveland Clinic in July 2023. She submitted her medical records along with an urgent letter pleading for assistance, expressing that she believed something was fundamentally wrong with her health. The Cleveland Clinic responded swiftly, arranging two full days of extensive testing.

The results were alarming: her blood work raised concerns, leading to immediate follow-up biopsies. “That was kind of scary,” Williams admitted. Initial tests indicated abnormalities in her urine and bone marrow, ultimately resulting in a diagnosis of multiple myeloma, a type of blood cancer that could affect kidney function. Despite undergoing nearly six months of chemotherapy and immunotherapy, her condition showed little improvement, propelling her medical team to reassess her treatment plan.

Dr Jagmeet Dhingra, a nephrologist from the Cleveland Clinic, noted that the lack of expected improvement in Williams’ condition prompted further investigation into her health. “If we are treating the underlying cause and she’s not improving, then what else are we looking at?” he questioned, affirming their commitment to uncover the true nature of her illness.

Further testing indicated that while Williams’ bone marrow had recovered, there were ongoing immune deposits in her kidneys. After ruling out several other conditions, doctors ultimately diagnosed her with immune complex membranoproliferative glomerulonephritis (IC-MPGN), a rare and complex kidney disease.

At the time of her diagnosis, there were no FDA-approved treatments specifically available for IC-MPGN. Standard therapies, including steroids and chemotherapy, provided limited relief and did not halt the progression of the disease. “Knowing there weren’t a lot of options, it just felt like I had to make it work,” Williams remarked, though she candidly shared that the medications left her feeling foggy and disoriented.

In late 2024, Dr Dhingra contacted Williams about an experimental medication called pegcetacoplan, which had shown promising results in clinical trials. Williams enrolled in the trial in February 2025, and she reported an immediate improvement in her health. “Right away, we saw change. I was back to my feisty self. I felt like I had freedom back,” she expressed.

Six months later, the injectable drug, now branded as Empaveli, was approved by the FDA as the first treatment for IC-MPGN. Williams’ condition has since stabilised, and she noted significant changes in her quality of life. “I don’t have that paranoia over me anymore about what I eat and getting enough sleep,” she said triumphantly, emphasising the transformative impact the medication has had on her daily life.

Michelle Williams’ experience serves not only as a reminder of the intricacies of navigating medical care but also as a testament to the necessity of self-advocacy in the face of health challenges. Her determination and resilience ultimately led her to a life-changing diagnosis and treatment, illustrating the importance of being proactive in one’s health journey.